back to Canada directory
canada clinical guidance

Suspected IBD (Crohn’s / ulcerative colitis): primary care work-up + referral

A Canadian clinical summary of suspected ibd (crohn’s / ulcerative colitis): primary care work-up + referral, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Alberta is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.

Alberta source: bounded use

This Alberta source is the exact provincial gastroenterology referral form for known or query IBD. It supports a complete referral package, not a pan-Canadian diagnostic threshold or initial-treatment algorithm.
sources for this section:AHS GI referral

Source-attributed clinical priorities

  • Use the Alberta gastroenterology referral requirements for a patient with query inflammatory bowel disease; they do not themselves diagnose Crohn disease or ulcerative colitis.
  • Document symptoms, duration and progression and include the source-requested blood, stool and fecal-calprotectin investigations when clinically appropriate.
  • Send previous colonoscopy and pathology when available and distinguish a routine query-IBD referral from acute severe disease requiring hospital assessment.
  • The source lists the information expected for an Alberta query-IBD referral; its test list is not a stand-alone diagnostic rule.
sources for this section:AHS GI referral

Practical assessment and management workflow

1
Document symptom duration and progression, blood, diarrhea, weight change, family history, perianal features and any prior gastroenterology care.
2
Include the source-requested complete blood count, stool culture, C. difficile, C-reactive protein, celiac serology and fecal calprotectin as clinically appropriate.
3
Attach prior colonoscopy and pathology when available and identify which investigations are complete versus ordered.
4
Use the current Alberta referral channel and continue clinical monitoring rather than assuming form submission transfers responsibility.
sources for this section:AHS GI referral

Safety, red flags and urgent escalation

  • Severe bleeding, systemic toxicity, obstruction, peritonism or major dehydration requires acute assessment rather than a routine referral form.
  • A fecal-calprotectin result does not by itself confirm or exclude all inflammatory bowel disease.
  • Do not infer induction treatment, imaging sequences or a national referral threshold from this administrative clinical pathway.
sources for this section:AHS GI referral

Confirm the local pathway before acting

Alberta is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.
sources for this section:AHS GI referral

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:AHS GI referral

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Alberta Health ServicesGastroenterology/Endoscopy Referral — suspected inflammatory bowel disease requirementsCurrent provincial referral form checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.